Pathology of genetically engineered mouse models of pancreatic exocrine cancer: Consensus report and recommendations

Ralph H Hruban, N. Volkan Adsay, Jorge Albores-Saavedra, Miriam R. Anver, Andrew V. Biankin, Gregory P. Boivin, Emma E. Furth, Toru Furukawa, Alison Klein, David S. Klimstra, Gunter Kloppel, Gregory Y. Lauwers, Daniel S. Longnecker, Jutta Luttges, Anirban Maitra, G. Johan A Offerhaus, Lucía Pérez-Gallego, Mark Redston, David A. Tuveson

Research output: Contribution to journalArticle

Abstract

Several diverse genetically engineered mouse models of pancreatic exocrine neoplasia have been developed. These mouse models have a spectrum of pathologic changes; however, until now, there has been no uniform nomenclature to characterize these changes. An international workshop, sponsored by The National Cancer Institute and the University of Pennsylvania, was held from December 1 to 3, 2004 with the goal of establishing an internationally accepted uniform nomenclature for the pathology of genetically engineered mouse models of pancreatic exocrine neoplasia. The pancreatic pathology in 12 existing mouse models of pancreatic neoplasia was reviewed at this workshop, and a standardized nomenclature with definitions and associated images was developed. It is our intention that this nomenclature will standardize the reporting of genetically engineered mouse models of pancreatic exocrine neoplasia, that it will facilitate comparisons between genetically engineered mouse models and human pancreatic disease, and that it will be broad enough to accommodate newly emerging mouse models of pancreatic neoplasia.

Original languageEnglish (US)
Pages (from-to)95-106
Number of pages12
JournalCancer Research
Volume66
Issue number1
DOIs
StatePublished - Jan 1 2006

Fingerprint

Pancreatic Neoplasms
Consensus
Pathology
Terminology
Neoplasms
Education
Pancreatic Diseases
National Cancer Institute (U.S.)

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Hruban, R. H., Adsay, N. V., Albores-Saavedra, J., Anver, M. R., Biankin, A. V., Boivin, G. P., ... Tuveson, D. A. (2006). Pathology of genetically engineered mouse models of pancreatic exocrine cancer: Consensus report and recommendations. Cancer Research, 66(1), 95-106. https://doi.org/10.1158/0008-5472.CAN-05-2168

Pathology of genetically engineered mouse models of pancreatic exocrine cancer : Consensus report and recommendations. / Hruban, Ralph H; Adsay, N. Volkan; Albores-Saavedra, Jorge; Anver, Miriam R.; Biankin, Andrew V.; Boivin, Gregory P.; Furth, Emma E.; Furukawa, Toru; Klein, Alison; Klimstra, David S.; Kloppel, Gunter; Lauwers, Gregory Y.; Longnecker, Daniel S.; Luttges, Jutta; Maitra, Anirban; Offerhaus, G. Johan A; Pérez-Gallego, Lucía; Redston, Mark; Tuveson, David A.

In: Cancer Research, Vol. 66, No. 1, 01.01.2006, p. 95-106.

Research output: Contribution to journalArticle

Hruban, RH, Adsay, NV, Albores-Saavedra, J, Anver, MR, Biankin, AV, Boivin, GP, Furth, EE, Furukawa, T, Klein, A, Klimstra, DS, Kloppel, G, Lauwers, GY, Longnecker, DS, Luttges, J, Maitra, A, Offerhaus, GJA, Pérez-Gallego, L, Redston, M & Tuveson, DA 2006, 'Pathology of genetically engineered mouse models of pancreatic exocrine cancer: Consensus report and recommendations', Cancer Research, vol. 66, no. 1, pp. 95-106. https://doi.org/10.1158/0008-5472.CAN-05-2168
Hruban, Ralph H ; Adsay, N. Volkan ; Albores-Saavedra, Jorge ; Anver, Miriam R. ; Biankin, Andrew V. ; Boivin, Gregory P. ; Furth, Emma E. ; Furukawa, Toru ; Klein, Alison ; Klimstra, David S. ; Kloppel, Gunter ; Lauwers, Gregory Y. ; Longnecker, Daniel S. ; Luttges, Jutta ; Maitra, Anirban ; Offerhaus, G. Johan A ; Pérez-Gallego, Lucía ; Redston, Mark ; Tuveson, David A. / Pathology of genetically engineered mouse models of pancreatic exocrine cancer : Consensus report and recommendations. In: Cancer Research. 2006 ; Vol. 66, No. 1. pp. 95-106.
@article{99f4fb887e1d498f8d967b96905e3f55,
title = "Pathology of genetically engineered mouse models of pancreatic exocrine cancer: Consensus report and recommendations",
abstract = "Several diverse genetically engineered mouse models of pancreatic exocrine neoplasia have been developed. These mouse models have a spectrum of pathologic changes; however, until now, there has been no uniform nomenclature to characterize these changes. An international workshop, sponsored by The National Cancer Institute and the University of Pennsylvania, was held from December 1 to 3, 2004 with the goal of establishing an internationally accepted uniform nomenclature for the pathology of genetically engineered mouse models of pancreatic exocrine neoplasia. The pancreatic pathology in 12 existing mouse models of pancreatic neoplasia was reviewed at this workshop, and a standardized nomenclature with definitions and associated images was developed. It is our intention that this nomenclature will standardize the reporting of genetically engineered mouse models of pancreatic exocrine neoplasia, that it will facilitate comparisons between genetically engineered mouse models and human pancreatic disease, and that it will be broad enough to accommodate newly emerging mouse models of pancreatic neoplasia.",
author = "Hruban, {Ralph H} and Adsay, {N. Volkan} and Jorge Albores-Saavedra and Anver, {Miriam R.} and Biankin, {Andrew V.} and Boivin, {Gregory P.} and Furth, {Emma E.} and Toru Furukawa and Alison Klein and Klimstra, {David S.} and Gunter Kloppel and Lauwers, {Gregory Y.} and Longnecker, {Daniel S.} and Jutta Luttges and Anirban Maitra and Offerhaus, {G. Johan A} and Luc{\'i}a P{\'e}rez-Gallego and Mark Redston and Tuveson, {David A.}",
year = "2006",
month = "1",
day = "1",
doi = "10.1158/0008-5472.CAN-05-2168",
language = "English (US)",
volume = "66",
pages = "95--106",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "1",

}

TY - JOUR

T1 - Pathology of genetically engineered mouse models of pancreatic exocrine cancer

T2 - Consensus report and recommendations

AU - Hruban, Ralph H

AU - Adsay, N. Volkan

AU - Albores-Saavedra, Jorge

AU - Anver, Miriam R.

AU - Biankin, Andrew V.

AU - Boivin, Gregory P.

AU - Furth, Emma E.

AU - Furukawa, Toru

AU - Klein, Alison

AU - Klimstra, David S.

AU - Kloppel, Gunter

AU - Lauwers, Gregory Y.

AU - Longnecker, Daniel S.

AU - Luttges, Jutta

AU - Maitra, Anirban

AU - Offerhaus, G. Johan A

AU - Pérez-Gallego, Lucía

AU - Redston, Mark

AU - Tuveson, David A.

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Several diverse genetically engineered mouse models of pancreatic exocrine neoplasia have been developed. These mouse models have a spectrum of pathologic changes; however, until now, there has been no uniform nomenclature to characterize these changes. An international workshop, sponsored by The National Cancer Institute and the University of Pennsylvania, was held from December 1 to 3, 2004 with the goal of establishing an internationally accepted uniform nomenclature for the pathology of genetically engineered mouse models of pancreatic exocrine neoplasia. The pancreatic pathology in 12 existing mouse models of pancreatic neoplasia was reviewed at this workshop, and a standardized nomenclature with definitions and associated images was developed. It is our intention that this nomenclature will standardize the reporting of genetically engineered mouse models of pancreatic exocrine neoplasia, that it will facilitate comparisons between genetically engineered mouse models and human pancreatic disease, and that it will be broad enough to accommodate newly emerging mouse models of pancreatic neoplasia.

AB - Several diverse genetically engineered mouse models of pancreatic exocrine neoplasia have been developed. These mouse models have a spectrum of pathologic changes; however, until now, there has been no uniform nomenclature to characterize these changes. An international workshop, sponsored by The National Cancer Institute and the University of Pennsylvania, was held from December 1 to 3, 2004 with the goal of establishing an internationally accepted uniform nomenclature for the pathology of genetically engineered mouse models of pancreatic exocrine neoplasia. The pancreatic pathology in 12 existing mouse models of pancreatic neoplasia was reviewed at this workshop, and a standardized nomenclature with definitions and associated images was developed. It is our intention that this nomenclature will standardize the reporting of genetically engineered mouse models of pancreatic exocrine neoplasia, that it will facilitate comparisons between genetically engineered mouse models and human pancreatic disease, and that it will be broad enough to accommodate newly emerging mouse models of pancreatic neoplasia.

UR - http://www.scopus.com/inward/record.url?scp=31544467540&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=31544467540&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-05-2168

DO - 10.1158/0008-5472.CAN-05-2168

M3 - Article

C2 - 16397221

AN - SCOPUS:31544467540

VL - 66

SP - 95

EP - 106

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 1

ER -